Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older

NCT02082054 is registered in ClinicalTrials.gov with Magna Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02082054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Lead sponsor
Magna Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2014
Completion date
May 31, 2014
Enrollment
125 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, seasonal, allergic